Canadian Vaping Association: More evidence emerges that vaping can help smokers quit

Market
Jun.02.2022
For the better part of the last decade, the Canadian Vaping Association (CVA) has advocated for nicotine vape products as a tool to quit smoking. However, opponents of vaping have created confusion amongst smokers and the public through dishonest claims that vaping is ineffective for quitting smoking.

For the better part of the last decade, the Canadian Vaping Association (CVA) has advocated for nicotine vape products as a tool to quit smoking. However, opponents of vaping have created confusion amongst smokers and the public through dishonest claims that vaping is ineffective for quitting smoking.
 

“The claim that e-cigs can't help people quit smoking is now so plainly false that anybody making it not only discredits themselves, but worse still, undermines public confidence in science,” said Mark Dockrell from Public Health England.

Vaping is currently the most widely used smoking intervention as demonstrated through clinical trials and systematic reviews. An international review, produced by Cochrane, a global network of independent researchers, has reviewed 50 of the top studies on vaping’s efficacy. The review found that nicotine-containing e-cigarettes are superior to Nicotine Replacement Therapy (NRT), non-nicotine-containing e-cigarettes and behavioural interventions in helping people quit cigarettes.

Another study, published in the American Medical Association Journal, found that “those who were using e-cigarettes daily at the end of the study were 8-fold more likely to quit cigarettes altogether. They were also almost 10-fold more likely to stop smoking cigarettes every day.”

Additionally, Public Health England’s (PHE) seventh independent report on vaping in England, carried out by researchers at King’s College London, found that using a vaping product as part of a quit attempt in local stop smoking services had some of the highest quit success rates – between 59.7% and 74% in 2019 and 2020.

Although science continues to prove vaping to be an effective harm reduction tool, vaping regulation has become increasingly restrictive and even prohibitive in some regions.

“It is illogical and reckless to promote policies that would restrict or even ban the sale of vaping products in places where cigarettes are available. There is really no precedent in public health where a much safer medicine or medical device or procedure is introduced and then is heavily restricted or prohibited, while the deadly medicine/device/procedure is allowed to continue. This is exactly what is happening with e-cigarettes/vaping and all safer nicotine delivery systems,” said Dr. Mark Tyndall.

“Smoking continues to be the leading cause of preventable death and illness in Canada. Vaping presents a tool to reduce smoking rates faster than previously thought possible. For the greatest potential benefit to public health, smokers need clear messaging that vaping is an option to reduce the harm caused by combustible tobacco,” said Darryl Tempest, Government Relations Counsel to the CVA Board.

About the CVA: The Canadian Vaping Association is a registered national, not-for-profit organization, established as the voice for the Canadian vaping industry. Founded in 2014, the CVA represents over 200 retail and online vaping businesses in Canada. CVA’s membership does not including tobacco companies or affiliates.

 

 

Source:globenewswire

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Smoore’s first-half 2026 revenue rose 19.9%, but the results revealed growing structural risks beneath the headline growth. Heat-not-burn contributed about 61% of incremental revenue and remains driven largely by one core customer, while traditional vaping markets diverged, own-brand growth slowed and China enterprise revenue declined further. Gross profit and adjusted profit lagged revenue growth, while second-quarter revenue growth slowed to about 1.9%, putting greater focus on the quality, concentration and sustainability of Smoore’s expansion.
Capital Markets
Aug.20
UK Vape Duty Starts in October as Hayati, DOJO and Others Launch Lower-Capacity Products With Lower Per-Unit Tax
UK Vape Duty Starts in October as Hayati, DOJO and Others Launch Lower-Capacity Products With Lower Per-Unit Tax
The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Ahead of implementation, DOJO, PIXL and Hayati have introduced or been reported to be adding lower-capacity tiers alongside larger products. DOJO has added a 6ml BLAST7K Fresh below its 10ml BLAST10K Fresh, PIXL offers both a 12ml 8000 and a 6ml 5K, while retailer Ninja Vapes says Hayati is preparing a 7ml 4K alongside its existing 12ml 6K. The pattern points to a growing lower-capacity tier in the UK market, although the brands have not all explicitly linked the changes to the new duty.
Sep.23
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10